FDA Grants Market Authorization to Light-Therapy System for Dry AMD
The FDA announced marketing authorization of a form of light therapy as the first-ever treatment for dry age-related macular degeneration (AMD). LumiThera’s Valeda Light Delivery
The FDA announced marketing authorization of a form of light therapy as the first-ever treatment for dry age-related macular degeneration (AMD). LumiThera’s Valeda Light Delivery
Biophytis / Key word(s): Miscellaneous Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia 11-Sep-2023 / 07:00 CET/CEST Biophytis obtains
Extended infusion of beta-lactam therapy was associated with reduced mortality in patients with severe gram-negative bloodstream infections, according to a retrospective cohort study. At 90